March 13, 2025—Perfuze, an Ireland-based developer of catheter-based aspiration technology for the treatment of acute ischemic stroke, announced that it has received FDA 510(k) clearance for its ...

The federal government will spend $20 million to expand the only local manufacturing facility of IV fluids. Production of the medicine is expected to jump from 60 million units a year to 80 ...